Guggenheim Initiates Coverage on Pharvaris (NASDAQ:PHVS)
Investment analysts at Guggenheim began coverage on shares of Pharvaris (NASDAQ:PHVS – Get Free Report) in a research report issued on Wednesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $32.00 price target on the stock. Guggenheim’s target price would suggest a potential upside of 85.72% from the company’s current price. A […]
